LPL and atherosclerosis: In contrast, individuals with bi-allelic loss-of-function variants in genes with a negative impact on LPL activity (e.g., ANGPTL3, ANGPTL4, ANGPTL8, APOC3) have reduced plasma TRL levels and are at reduced risk for ASCVD (10, 11, 12, 13).